Fig. 5
From: Development and validation of an immune gene-set based prognostic signature for soft tissue sarcoma
Validation of immune-related prognostic signature in the testing cohort. a. The risk score distribution of patients in the testing cohort. b. Survival status scatter plots for patients in the testing cohort. c. Time-dependent ROC curve analysis of the immune-related prognostic signature. d. Kaplan-Meier of overall survival in high- and low-risk group of the sarcoma patients in testing cohort